Glenmark Pharma Share Price News: Glenmark Pharma shares are facing selling pressure on Dalal Street after the drug maker reported a weaker-than-expected set of results for the quarter ended June 30 (Q1 FY26).
Glenmark Pharma Share Price News: Glenmark Pharma shares are facing selling pressure on Dalal Street after the drug maker reported a weaker-than-expected set of results for the quarter ended June 30 (Q1 FY26).